Global Antimicrobial Peptides Market Insights: Impact of COVID-19 and Future Expectations to 2025

SKU ID : Maia- 16436425

Publishing Date : 16-Sep-2020

No. of pages : 101

PRICE
3260
6520


  • The Antimicrobial Peptides market revenue was 168 Million USD in 2019, and will reach 395 Million USD in 2025, with a CAGR of 15.28% during 2020-2025. Antimicrobial peptides (AMPs), also known as host defense peptides, are short and generally positively charged peptides found in a wide variety of life forms from microorganisms to humans. Most AMPs have the ability to kill microbial pathogens directly, whereas others act indirectly by modulating the host defense systems. Antibacterial and Antimicrobial have some different function, antibacterial only kill bacteria and antimicrobial kill all microorganisms.
    This report elaborates the market size, market characteristics, and market growth of the Antimicrobial Peptides industry, and breaks down according to the type, application, and consumption area of Antimicrobial Peptides. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.

    In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Antimicrobial Peptides in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
    Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
    In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.

    Key players in the global Antimicrobial Peptides market covered in Chapter 11:
    Merck & Co., Inc.
    GenScript Biotech Corporation
    Roche Holding AG
    Shenzhen Sunsmile Biotechnology Co.,Ltd
    GeneLinx International, Inc.
    InvivoGen
    Linzhou Sinagri Yingtai Biological Peptide Co., Ltd.
    Sigma-Aldrich Corporation
    Abeona Therapeutics Inc.
    EnBiotix, Inc.

    In Chapter 3, on the basis of types, the Antimicrobial Peptides market from 2015 to 2025 is primarily split into:
    Recombinant
    Natural

    In Chapter 4, on the basis of applications, the Antimicrobial Peptides market from 2015 to 2025 covers:
    Pharmaceutical
    Animal Feed
    Food Additive
    Agriculture
    Cosmetics
    Others

    Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
    North America (Covered in Chapter 6)
    United States
    Canada
    Mexico
    Europe (Covered in Chapter 7)
    Germany
    UK
    France
    Italy
    Spain
    Russia
    Others
    Asia-Pacific (Covered in Chapter 8)
    China
    Japan
    South Korea
    Australia
    India
    Middle East and Africa (Covered in Chapter 9)
    Saudi Arabia
    UAE
    Egypt
    South Africa
    South America (Covered in Chapter 10)
    Brazil
    Argentina
    Columbia

    Years considered for this report:


    Historical Years:

    2015-2019

    Base Year:

    2019

    Estimated Year:

    2020

    Forecast Period:

    2020-2025

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports